Fig. 7.
Fig. 7. Gr-1mid VLA-4+ population is diminished in IL-5–treated Stat5a−/− mice and Stat5b−/− mice. / Mice were injected intraperitoneally with rmIL-5 as described in Figure6. Forty-eight hours after the last injection, mice were killed and cells in the peritoneal cavity were stained with anti-VLA-4 FITC and anti-Gr-1 APC. Shown are representative FACS profiles from 5 mice in each group.

Gr-1mid VLA-4+ population is diminished in IL-5–treated Stat5a−/− mice and Stat5b−/− mice.

Mice were injected intraperitoneally with rmIL-5 as described in Figure6. Forty-eight hours after the last injection, mice were killed and cells in the peritoneal cavity were stained with anti-VLA-4 FITC and anti-Gr-1 APC. Shown are representative FACS profiles from 5 mice in each group.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal